With 1.07 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.59 million shares. During the session, the Specialty Industrial Machinery company that operates in wider Industrials sector, reached to the highest price of $110.73 whereas the lowest price it dropped to was $109.11. The 52-week range on EMR shows that it touched its highest point at $116.76 and its lowest point at $83.10 during that stretch. It currently has a 1-year price target of $130.96. With its current market cap of 62.75 billion, EMR has annualized dividend of $2.10 while the current yield stands at 1.91%. EMR paid its most recent dividend on 1715817600, while the ex-dividend date for that was 1715817600. Beta for the stock currently stands at 1.32.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EMR was up-trending over the past week, with a rise of 3.35%, but this was up by 0.60% over a month. Three-month performance dropped to -3.40% while six-month performance rose 14.39%. The stock gained 20.85% in the past year, while it has gained 12.69% so far this year. A look at the trailing 12-month EPS for EMR yields 0.21 with Next year EPS estimates of 6.02. For the next quarter, that number is 1.41. This implies an EPS growth rate of 23.03% for this year and 10.20% for next year.
Float and Shares Shorts:
At present, 572.00 million EMR shares are outstanding with a float of 569.92 million shares on hand for trading. On 2024-06-14, short shares totaled 6.5 million, which was 114.00000000000001 higher than short shares on 1715731200. In addition to Mr. Surendralal Lanca Karsanbhai as the firm’s President, CEO & Director, Mr. Michael J. Baughman serves as its Executive VP, Chief Accounting Officer & CFO.
Institutional Ownership:
Through their ownership of 0.77874 of EMR’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-03-31, EMR reported revenue of $4376000000.0 and operating income of $715000000.0. The EBITDA in the recently reported quarter was $1257000000.0 and diluted EPS was $0.87.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EMR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
